26
|
Di Dia A, Depalma S, Bresciani S, Maggio A, Miranti A, Poli M, Gabriele P, Garibaldi E, Stasi M. PO-0945: Modeling and simulation of simultaneous using of two superficial hyperthermia antennas. Radiother Oncol 2016. [DOI: 10.1016/s0167-8140(16)32195-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
27
|
Palorini F, Rancati T, Cicchetti A, Improta I, Cozzarini C, Casanova Borca V, Degli Esposti C, Franco P, Garibaldi E, Girelli G, Maggio A, Micera R, Palombarini M, Pierelli A, Pignoli E, Simoni N, Vavassori V, Villa S, Valdagni R, Fiorino C. PO-0875: Multivariable models for urinary symptoms at 6-24 months after radical RT of prostate cancer. Radiother Oncol 2016. [DOI: 10.1016/s0167-8140(16)32125-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
28
|
Poli M, Bresciani S, Miranti A, Dia AD, Maggio A, Gatti M, Gabriele P, Stasi M. EP-1880: Validation of the use of digital camera for the prediction of skin toxicity in breast radiotherapy. Radiother Oncol 2016. [DOI: 10.1016/s0167-8140(16)33131-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
29
|
Gatti M, Belli G, Salatino A, Maggio A, Cattari G, Squintu S, Rivolin A, Ponzone R, Gabriele P. EP-1167: Radiation therapy and breast reconstruction: outcomes and complications in our experience. Radiother Oncol 2016. [DOI: 10.1016/s0167-8140(16)32417-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
30
|
Garibaldi E, Gabriele D, Maggio A, Garibaldi M, Delmastro E, Bresciani S, Sottile A, Stasi M, Gabriele P. EP-1361: Prognostic factors in 1080 prostate cancer treated with radical external beam radiotherapy. Radiother Oncol 2016. [DOI: 10.1016/s0167-8140(16)32611-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
31
|
Maggio A, Garibaldi E, Gabriele D, Bresciani S, Delmastro E, Di Dia A, Miranti A, Poli M, Gabriele P, Stasi M. PO-0752: Outcome of prostate cancer patients treated with 3DCRT: impact of rectal/bladder preparation. Radiother Oncol 2016. [DOI: 10.1016/s0167-8140(16)32002-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
32
|
Bresciani S, Poli M, Miranti A, Maggio A, Di Dia A, Bracco C, Stasi M. Characterization and comparison of two EPID-based software solutions for in-vivo dosimetry of VMAT treatments. Phys Med 2016. [DOI: 10.1016/j.ejmp.2016.01.022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/22/2022] Open
|
33
|
Palorini F, Rancati T, Cicchetti A, Improta I, Cozzarini C, Borca VC, Degli Esposti C, Franco P, Garibaldi E, Girelli G, Maggio A, Botti A, Palombarini M, Pierelli A, Pignoli E, Simoni N, Vavassori V, Villa S, Valdagni R, Fiorino C. Clinical and dose predictors for the incidence of late urinary symptoms after radical radiotherapy for prostate cancer. Phys Med 2016. [DOI: 10.1016/j.ejmp.2016.01.170] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
34
|
Poli M, Bracco C, Bresciani S, Maggio A, Di Dia A, Miranti A, Stasi M. Three years of experience with dose reduction by means of iterative reconstruction algorithm available on CT Siemens Somatom Definition Flash. Phys Med 2016. [DOI: 10.1016/j.ejmp.2016.01.300] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/22/2022] Open
|
35
|
Maggio A, Garibaldi E, Gabriele D, Bresciani S, Delmastro E, Di Dia A, Miranti A, Poli M, Gabriele P, Stasi M. Is the outcome of prostate cancer patients treated with 3D conformal radiotherapy influenced by rectal/bladder preparation? Phys Med 2016. [DOI: 10.1016/j.ejmp.2016.01.136] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
36
|
Giambona A, Damiani G, Vinciguerra M, Jakil C, Cannata M, Cassarà F, Picciotto F, Schillaci G, Cigna V, Renda D, Leto F, Passarello C, Maggio A. Incidence of haemoglobinopathies in Sicily: the impact of screening and prenatal diagnosis. Int J Clin Pract 2015; 69:1129-38. [PMID: 25727926 DOI: 10.1111/ijcp.12628] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
Abstract
BACKGROUND Haemoglobinopathies are a major public health problem in Sicily: it was estimated a frequency of 1/245 couples are at risk of haemoglobinopathies. This paper reviews legislative actions, prevention activities, carrier screening, genetic counselling, foetal sampling and laboratory methodology analysis evolution reporting the results of 30 years of prevention actions to assess the efficiency of our preventative programme in the control of haemoglobinopathies in Sicily. METHODS This programme consisted principally of five phases: legislative actions, public awareness campaign, carrier screening, genetic counselling and prenatal diagnosis. RESULTS These programmes have been very effective, which we can see from a greater public awareness of thalassaemia and its prevention in the target population furthermore by a marked decline in the incidence of thalassaemia major and sickle cell anaemia from 1 in 245 live births in the absence of prevention to 1 in 2000, with a reduction in about 85%. The residual cases were because of a conscious choice by expecting parents in relation to improved life expectancy as well as improved quality of life of the affected patients. CONCLUSION The study suggests that public health authorities should act and invest in a similar programme for prevention of thalassaemia, as well as in relation to the increased survival of patients and the consequent organ complications.
Collapse
|
37
|
Vinciguerra M, Passarello C, Cassarà F, Leto F, Cannata M, Calvaruso G, Di Maggio R, Renda D, Maggio A, Giambona A. Co-heredity of silent CAP + 1570 T>C (HBB:c*96T>C) defect and severe β-thal mutation: a cause of mild β-thalassemia intermedia. Int J Lab Hematol 2015; 38:17-26. [PMID: 26418075 DOI: 10.1111/ijlh.12433] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/03/2015] [Accepted: 08/05/2015] [Indexed: 11/29/2022]
Abstract
INTRODUCTION During an intensive screening program aimed at identifying the healthy carriers of thalassemia and the couples at risk of bearing an affected fetus, a rare single nucleotide variation (SNV), CAP + 1570 T > C (HBB:c*96T > C), located 12 nucleotides upstream of the polyadenylation signal in 3'UTR of the beta globin gene was identified. It was previously reported as a β+ thalassemia mutation and later as a plain polymorphism. METHODS Genotype identification of globin gene mutations was carried out using sequencing analysis, GAP-PCR, and MLPA methods. RESULTS CAP + 1570 T > C (HBB:c*96T > C) was found in 39 heterozygotes, in one case in homozygous state and in thirteen cases of co-inheritance of this nucleotide substitution with other mutations in globin genes. Carriers of this mutation showed a 'silent' phenotype without appreciable microcytosis and hypochromia, so they cannot be differentiated from noncarrier individuals. Compound heterozygotes for this mutation and severe β-thal mutations showed a variable phenotype ranging from β-thal carrier to mild form of β-thalassemia intermedia, revealing new aspects and allowing to better understand the clinical implications of this nucleotide substitution that can be classified as a silent β-thalassemic defect. CONCLUSION Data reported in this study indicate the need of investigating partner of β-thalassemia carrier by complete sequencing analysis of β-globin gene and of providing an appropriate genetic counseling for couples at risk undergoing prenatal diagnosis.
Collapse
|
38
|
Stasi M, Bresciani S, Miranti A, Di Dia A, Maggio A, Dispirito D. PO-0846: A retrospective analysis of 384 Tomotherapy per-patient verifications. Radiother Oncol 2015. [DOI: 10.1016/s0167-8140(15)40838-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
39
|
Palorini F, Rancati T, Cozzarini C, Carillo V, Casanova Borca V, Degli Esposti C, Franco P, Garibaldi E, Girelli E, Maggio A, Micera R, Palombarini M, Pierelli A, Pignoli E, Simoni N, Vavassori V, Villa S, Valdagni R, Fiorino C. OC-0255: Multi-variable models of acute urinary toxicity: final results of a large prospective study. Radiother Oncol 2015. [DOI: 10.1016/s0167-8140(15)40253-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
40
|
F. Pane SC, Maggio A. Abstract book. THALASSEMIA REPORTS 2014. [DOI: 10.4081/thal.2014.s1.abs] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
|
41
|
Pane F, Maggio A. Abstract Book. THALASSEMIA REPORTS 2014. [DOI: 10.4081/thal.2014.4725] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
Abstract
Relapsed/refractory AML patients have a poor prognosis, with CR rates of 1–30%, unless allogeneic hematopoietic stem cell transplantation (HSCT) is an available option [...]
Collapse
|
42
|
Carillo V, Botti A, Casanova Borca V, Cattari G, Civardi F, Cozzarini C, Degli Esposti C, Fiorino C, Franco P, Girelli G, Maggio A, Muraglia A, Palombarini M, Pierelli A, Pignoli E, Rancati T, Valdagni R, Vavassori V, Villa S, Zeverino M. 41: Modelling acute urinary toxicity after radiotherapy for prostate cancer. Radiother Oncol 2014. [DOI: 10.1016/s0167-8140(15)34062-7] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
43
|
Gregory SG, Holzwarth VR, Donati JF, Hussain GAJ, Montmerle T, Alecian E, Alencar SHP, Argiroffi C, Audard M, Bouvier J, Damiani F, Güdel M, Huenemoerder DP, Kastner JH, Maggio A, Sacco GG, Wade GA. The magnetosphere of the close accreting PMS binary V4046 Sgr. EPJ WEB OF CONFERENCES 2014. [DOI: 10.1051/epjconf/20136408009] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
44
|
Bresciani S, Miranti A, Maggio A, Di Dia A, Stasi M. PO-0815: Pre-treatment IMRT quality assurance: from ROC curves to Quantec constraints. Radiother Oncol 2014. [DOI: 10.1016/s0167-8140(15)30933-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
45
|
Cutaia C, Maggio A, Garibaldi E, Bresciani S, Di Dia A, Cattari G, Del Mastro E, Gabriele P, Stasi M. PO-0980: Helical Tomotherapy dose-escalation feasability study for radical malignant pleural mesothelioma. Radiother Oncol 2014. [DOI: 10.1016/s0167-8140(15)31098-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
46
|
Cattari G, Garibaldi E, Cutaia C, Delmastro E, Maggio A, Bresciani S, Stasi M, Gabriele P. EP-1177: Pleural cavity radiotherapy with IMRT-SIB-IGRT by Tomotherapy for malignant pleural mesothelioma. Radiother Oncol 2014. [DOI: 10.1016/s0167-8140(15)31295-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
47
|
Gabriele P, Garibaldi E, Cattari G, Bracco C, Maggio A, Suma A, Petrilli G, Penduzzu G, Stasi M. EP-1432: New indicators for volumetric radiotherapy: A proposal. Radiother Oncol 2014. [DOI: 10.1016/s0167-8140(15)31550-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
48
|
Maggio A, Di Dia A, Bresciani S, Cutaia C, Miranti A, Stasi M. EP-1568: Dosimetric comparison between GPU and CPU cluster based Tomotherapy dose engine for different anatomical districts. Radiother Oncol 2014. [DOI: 10.1016/s0167-8140(15)31686-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
49
|
Jemia MB, Tundis R, Maggio A, Rosselli S, Senatore F, Menichini F, Bruno M, Kchouk M, Loizzo M. NMR-based quantification of rosmarinic and carnosic acids, GC–MS profile and bioactivity relevant to neurodegenerative disorders of Rosmarinus officinalis L. extracts. J Funct Foods 2013. [DOI: 10.1016/j.jff.2013.09.008] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
50
|
Bresciani S, Cattari G, Garibaldi E, Di Dia A, Delmastro E, Maggio A, Stasi M, Gabriele P. EP-1202: Extended fields irradiation in the upper abdomen with Tomotherapy: planning optimization and dosimetric analysis. Radiother Oncol 2013. [DOI: 10.1016/s0167-8140(15)33508-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|